Cargando…

Acute and cumulative effects of carboplatin on renal function.

Carboplatin, a cisplatinum analogue, has no reported nephrotoxicity in phase I/II studies, assessed by creatinine clearance. We prospectively determined renal function in 10 untreated lung cancer patients with normal baseline renal function, treated with carboplatin 400 mg m-2 day 1 and vincristine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sleijfer, D. T., Smit, E. F., Meijer, S., Mulder, N. H., Postmus, P. E.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1989
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247337/ https://www.ncbi.nlm.nih.gov/pubmed/2679841

Ejemplares similares

Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
por: Groen, H. J., et al.
Publicado: (1995)

Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis.
por: Sleijfer, S., et al.
Publicado: (1996)

Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days.
por: Mulder, P. O., et al.
Publicado: (1990)

Carboplatin and renal function in children.
por: Stevens, M. C., et al.
Publicado: (1991)

The effect of carboplatin on renal function in patients with metastatic germ cell tumours.
por: Mason, M. D., et al.
Publicado: (1991)

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
por: Biesma, B., et al.
Publicado: (1992)

Application of prolonged microdialysis sampling in carboplatin-treated cancer patients
por: Konings, Inge R. H. M., et al.
Publicado: (2008)

Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I
por: Fehr, Martin, et al.
Publicado: (2018)

Haematological toxicity of carboplatin in rats.
por: Siddik, Z. H., et al.
Publicado: (1987)

Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.
por: Sleijfer, S., et al.
Publicado: (1995)

Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients.
por: Janssen, R. A., et al.
Publicado: (1995)

High dose etoposide for brain metastases of small cell lung cancer. A phase II study. The EORTC Lung Cancer Cooperative Group.
por: Postmus, P. E., et al.
Publicado: (1989)

Estimation of renal function and its potential impact on carboplatin dosing in children with cancer
por: Chinnaswamy, G, et al.
Publicado: (2008)

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
por: Gridelli, Cesare, et al.
Publicado: (2018)

High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors.
por: Lyttelton, M. P., et al.
Publicado: (1998)

Peripheral blood lymphocyte number and phenotype prior to therapy correlate with response in subcutaneously applied rIL-2 therapy of renal cell carcinoma.
por: Janssen, R. A., et al.
Publicado: (1992)

A Panel of High Resolution Melting (HRM) Technology-Based Assays with Direct Sequencing Possibility for Effective Mutation Screening of EGFR and K-ras Genes
por: Heideman, D. A. M., et al.
Publicado: (2009)

A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer.
por: Rankin, E. M., et al.
Publicado: (1992)

How nephrotoxic is carboplatin?
por: Hardy, J. R., et al.
Publicado: (1990)

Cumulative fluid accumulation is associated with the development of acute kidney injury and non-recovery of renal function: a retrospective analysis
por: Zhang, Jing, et al.
Publicado: (2019)

Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response.
por: Martens, A., et al.
Publicado: (1993)

Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989)

Cisplatin in breast cancer.
por: Willemse, P., et al.
Publicado: (1993)

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity
por: Helbekkmo, N, et al.
Publicado: (2007)

Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation
por: Mulder, E.E.A.P., et al.
Publicado: (2021)

Reduction of carboplatin induced emesis by ondansetron.
por: Harvey, V. J., et al.
Publicado: (1991)

A phase II study of high dose epirubicin in unresectable non small cell lung cancer.
por: Smit, E. F., et al.
Publicado: (1992)

Carboplatin +/− Topotecan Ophthalmic Artery Chemosurgery for Intraocular Retinoblastoma
por: Francis, Jasmine H., et al.
Publicado: (2013)

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.
por: Mulder, N. H., et al.
Publicado: (1990)

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
por: Mulder, N. H., et al.
Publicado: (1992)

Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5- fluorouracil in locally advanced nasopharyngeal carcinoma
por: Dechaphunkul, Tanadech, et al.
Publicado: (2011)

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer.
por: Smit, E. F., et al.
Publicado: (1998)

Comparison of Renal Functions Evaluated by Measured Glomerular Filtration Rate in Patients Treated With Cisplatin, Carboplatin, and Oxaliplatin
por: Choudhary, Rajnee, et al.
Publicado: (2023)

Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study.
por: Groen, H. J., et al.
Publicado: (1995)

Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2.
por: Kroesen, B. J., et al.
Publicado: (1994)

A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide.
por: McClay, E. F., et al.
Publicado: (1993)

Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
por: Ruggiero, Antonio, et al.
Publicado: (2017)

Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.
por: Bakker, M., et al.
Publicado: (1995)

Estimation of Benchmark Dose of Cumulative Cadmium Exposure for Renal Tubular Effect
por: Nogawa, Kazuhiro, et al.
Publicado: (2021)

Cumulative effect in transfusion related acute lung injury
por: Jabbari, Ali, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1af06gmv83bon3act6a8f0p71p